Xiao Liu
机构：Weifang Medical University, Target (United States), Shandong University of Aeronautics, Sun Yat-sen University, Beijing University of Chinese Medicine, Yantai University, Shaanxi University of Technology, American Association of Colleges of Pharmacy, Chinese Academy of Sciences, Nantong University, Huazhong Agricultural University, Beijing Normal University, Hefei Institutes of Physical Science, Soochow University, Affiliated Hospital of Nantong University, Kochi Medical School Hospital, Nantong Tumor Hospital, Shandong Academy of Agricultural Sciences, Fifth Affiliated Hospital of Sun Yat-sen University, Anhui Institute of Optics and Fine Mechanics, VIB-UGent Center for Inflammation Research, Shandong Academy of Sciences, Beijing Hospital of Traditional Chinese Medicine, Chambroad Chemical Industry Research Institute (China), Ministry of Education, Hangzhou Dianzi University, Yangzhou University, The University of Texas at Austin · ORCID：0000-0001-9701-0675
发表论文 175 篇 · 总被引 3277 次 · h-index 31
代表论文
- Emergence and global spread of a dominant multidrug-resistant clade within Acinetobacter baumannii (2025 · Nature Communications · 被引 58)
- Single-cell and spatial transcriptomics reveal mechanisms of radioresistance and immune escape in recurrent nasopharyngeal carcinoma (2025 · Nature Genetics · 被引 23)
- Complete pathway elucidation of echinacoside in Cistanche tubulosa and de novo biosynthesis of phenylethanoid glycosides (2025 · Nature Communications · 被引 21)
- Novel Ru(II) Complexes as Type-I/-II Photosensitizers for Multimodal Hypoxia-Tolerant Chemo-Photodynamic/Immune Therapy (2025 · Molecular Pharmaceutics · 被引 14)
- p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation (2025 · Frontiers in Oncology · 被引 9)
- Refining the Substrate-Cofactor Disposition Model of Hyoscyamine 6β-Hydroxylase Catalysis Using Hyoscyamine Analogs (2025 · Journal of the American Chemical Society · 被引 6)